Page 21 - Neurocrine Biosciences Company Profile News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Neurocrine biosciences company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Neurocrine Biosciences Company Profile Today - Breaking & Trending Today

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Given Average Rating of "Moderate Buy" by Brokerages

Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Rating) have received a consensus recommendation of “Moderate Buy” from the twenty-one analysts that are presently covering the stock, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation, ten have issued a buy recommendation and one has assigned a strong buy recommendation to […] ....

San Diego , United States , Williamh Rastetter , Kevinc Gorman , Neurocrine Biosciences , Wyliew Vale , Royal Bank , Acadian Asset Management , Wells Fargo Company , Neurocrine Biosciences Company Profile , Bessemer Group Inc , Kb Financial Partners , Neurocrine Biosciences Inc , Covestor Ltd , Piershale Financial Group Inc , Get Rating , Biosciences Trading Down , Director William , Asset Management , Financial Group , Neurocrine Biosciences Daily , Nasdaq Nbix ,

Neurocrine Biosciences (NASDAQ:NBIX) Now Covered by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Neurocrine Biosciences (NASDAQ:NBIX – Get Rating) in a report released on Thursday morning. The firm issued a strong-buy rating on the stock. Several other equities research analysts have also recently commented on NBIX. Piper Sandler dropped their target price on Neurocrine Biosciences from $103.00 to $95.00 and set a […] ....

New Zealand General , New Zealand , San Diego , United States , Wyliew Vale , Julie Cooke , Kevinc Gorman , Neurocrine Biosciences , Piper Sandler , Blackrock Inc , Wellington Management Group , Armistice Capital , Norges Bank , Neurocrine Biosciences Company Profile , Neurocrine Biosciences Inc , Canaccord Genuity Group , Securities Exchange Commission , Get Rating , Genuity Group , Moderate Buy , Exchange Commission , Neurocrine Biosciences Daily , Nasdaq Nbix , Initiated Coverage , Stocknews Com ,

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by First Trust Advisors LP

First Trust Advisors LP trimmed its stake in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Rating) by 11.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 673,718 shares of the company’s stock after selling 91,049 shares during the quarter. First Trust Advisors […] ....

San Diego , United States , Kevinc Gorman , Wyliew Vale , Neurocrine Biosciences , Williamh Rastetter , Canaccord Genuity Group , Securities Exchange Commission , Hightower Advisors , Financial Services Group Inc , Acadian Asset Management , Dimensional Fund Advisors , Neurocrine Biosciences Company Profile , First Trust Advisors , Neurocrine Biosciences Inc , Exchange Commission , Rice Hall James Associates , Royal Bank , Get Rating , Trust Advisors , Hall James , Tower Advisors , Services Group , Asset Management , Fund Advisors , Director William ,

Motley Fool Asset Management LLC Invests $206,000 in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

Motley Fool Asset Management LLC bought a new position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Rating) during the fourth quarter, according to its most recent filing with the SEC. The fund bought 1,721 shares of the company’s stock, valued at approximately $206,000. A number of other hedge funds also recently made changes […] ....

San Diego , United States , Eiry Roberts , Neurocrine Biosciences , Kevinc Gorman , Piper Sandler , Wyliew Vale , Zurcher Kantonalbank Zurich Cantonalbank , Neurocrine Biosciences Inc , Jupiter Asset Management Ltd , Securities Exchange Commission , Cantor Fitzgerald , Canaccord Genuity Group , Motley Fool Asset Management , Morgan Stanley , Neurocrine Biosciences Company Profile , Get Rating , Sigma Investments , Kantonalbank Zurich Cantonalbank , Asset Management , Arizona State Retirement System , State Retirement System , Exchange Commission , Visit Holdingschannel , Neurocrine Biosciences Daily , Nasdaq Nbix ,

Neurocrine Biosciences (NASDAQ:NBIX) PT Lowered to $125.00 at Barclays

Neurocrine Biosciences (NASDAQ:NBIX – Get Rating) had its target price cut by Barclays from $131.00 to $125.00 in a research note issued to investors on Thursday, The Fly reports. Several other research analysts have also recently issued reports on NBIX. StockNews.com initiated coverage on Neurocrine Biosciences in a report on Thursday, March 16th. They issued […] ....

San Diego , United States , Eric Benevich , Neurocrine Biosciences , Julie Cooke , Kevinc Gorman , Wyliew Vale , First Republic Investment Management Inc , Larson Financial Group , Investors Services , Securities Exchange Commission , Neurocrine Biosciences Company Profile , Canaccord Genuity Group , Neurocrine Biosciences Inc , Wells Fargo Company , Securian Asset Management Inc , Meiji Yasuda Asset Management Co Ltd , Get Rating , Genuity Group , Moderate Buy , Exchange Commission , Republic Investment Management , Asset Management , Financial Group , Neurocrine Biosciences Daily , Nasdaq Nbix ,